Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 25 04 2019
revised: 12 06 2019
accepted: 21 06 2019
pubmed: 25 7 2019
medline: 16 7 2020
entrez: 24 7 2019
Statut: ppublish

Résumé

In 2018, EUCAST issued a warning regarding unreliable results of gradient strip tests for confirming vancomycin resistance in enterococci. We compared the performance of various diagnostic standard and confirmatory tests to identify and determine vanB-type vancomycin resistance. We analysed a collection of vanB-positive Enterococcus faecium isolates (n = 68) with low vancomycin MICs and compared the performance of VITEK® 2 (bioMérieux), broth microdilution and three gradient strip tests from different providers (Oxoid, Liofilchem and bioMérieux). For the latter we compared the standard procedure with a protocol with increased inoculum, a rich agar medium and a longer incubation time ('macromethod'). The sensitivity of VITEK® 2 was 81% compared with 72% for broth microdilution and 61%-63% for the three gradient strip tests using standard conditions. The macromethod substantially improved the performance of all strip tests resulting in a sensitivity of 89%-96% after 48 h of incubation. We recommend that EUCAST changes the present warning against the general use of MIC strips. When MIC strips are used to either exclude or confirm suspected vancomycin resistance in E. faecium, and a PCR is not available, the macromethod should be employed. For clinically relevant enterococci, where a rapid therapeutic decision is needed, a molecular test (e.g. PCR) should be favoured in order to save time and to further increase sensitivity.

Identifiants

pubmed: 31335935
pii: 5537362
doi: 10.1093/jac/dkz310
pmc: PMC6753474
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
VanB protein, Enterococcus 0
Vancomycin 6Q205EH1VU

Types de publication

Comparative Study Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2926-2929

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Références

J Clin Microbiol. 2008 Jun;46(6):1961-4
pubmed: 18434564
J Med Microbiol. 2011 Jul;60(Pt 7):945-9
pubmed: 21459908
Diagn Microbiol Infect Dis. 2011 Aug;70(4):512-21
pubmed: 21767707
Antimicrob Resist Infect Control. 2012 May 30;1(1):21
pubmed: 22958440
J Clin Microbiol. 2014 May;52(5):1582-9
pubmed: 24599985
J Clin Microbiol. 2014 Aug;52(8):2829-33
pubmed: 24871216
Antimicrob Resist Infect Control. 2018 Apr 24;7:54
pubmed: 29760912
BMC Microbiol. 2018 Dec 13;18(1):213
pubmed: 30545294
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782988

Auteurs

Ingo Klare (I)

National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

Jennifer K Bender (JK)

National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

Carola Fleige (C)

National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

Nancy Kriebel (N)

National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

Axel Hamprecht (A)

Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany and DZIF (German Centre for Infection Research), partner site Bonn-Cologne, Germany.

Sören Gatermann (S)

Department of Medical Microbiology, Institute for Medical Microbiology and Hygiene, Ruhr University Bochum, Bochum, Germany.

Guido Werner (G)

National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH